This post is an update to one posted about a month ago suggesting that the spread of the Coronavirus might impact the supply chain for some prescription meds.
Here is yesterday's (02/28/2020) FDA update on the current/possible impacts to the medical products supply chain by the Coronavirus. For those on prescription drugs, it might be good to monitor the FDA press releases and also to top-off all your current prescriptions. (Maybe even seeing if the prescribing MDs will increase script quantities; i.e., better to have too many now than not enough later.)
From the FDA press release:
"Since January 24, the FDA has been in touch with more than 180 manufacturers of human drugs, not only to remind them of applicable legal requirements for notifying the FDA of any anticipated supply disruptions, but also asking them to evaluate their entire supply chain, including active pharmaceutical ingredients (the main ingredient in the drug and part that produces the intended effects, e.g., acetaminophen) and other components manufactured in China.
Also, as part of our efforts, the FDA has identified about 20 other drugs, which solely source their active pharmaceutical ingredients or finished drug products from China. We have been in contact with those firms to assess whether they face any drug shortage risks due to the outbreak. None of these firms have reported any shortage to date. Also, these drugs are considered non-critical drugs.
We will remain in contact with manufacturers so that we can continue to assist them with any potential issues in the fastest way."
The full press release is here:
fda.gov/news-events/press-a...
This is looking more and more like the real deal, so disruptions to the supply chain for some drugs seems inevitable. Be Prepared to Stay/Be Well - K9
